CoChat

Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications

Open access
Drucker, Daniel J · 2020 · Endocrine Reviews

The DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.

Abstract

Individuals with diabetes are at increased risk for bacterial, mycotic, parasitic, and viral infections. The severe acute respiratory syndrome (SARS)-CoV-2 (also referred to as COVID-19) coronavirus pandemic highlights the importance of understanding shared disease pathophysiology potentially informing therapeutic choices in individuals with type 2 diabetes (T2D). Two coronavirus receptor proteins, angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase-4 (DPP4) are also established transducers of metabolic signals and pathways regulating inflammation, renal and cardiovascular physiology, and glucose homeostasis. Moreover, glucose-lowering agents such as the DPP4 inhibitors, widely used in subjects with T2D, are known to modify the biological activities of multiple immunomodulatory substrates. Here, we review the basic and clinical science spanning the intersections of diabetes, coronavirus infections, ACE2, and DPP4 biology, highlighting clinical relevance and evolving areas of uncertainty underlying the pathophysiology and treatment of T2D in the context of coronavirus infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endrev/bnaa011

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 130 references

Research works printed but not linked: 1

  1. Audit I. ICNARC Report on COVID-19 in Critical Care. In. April 10 2020 ed: London, UK: Intensive Care National Audit & Research Centre (ICNARC); 2020. https:// www.icnarc.org/About/Latest-News/2020/04/04/ Report-On-2249-Patients-Critically-Ill-With-Covid-19

Cited by

Items 301–400 of 433

Metadata

Authors
Drucker, D. J.
Affiliations
Mount Sinai Hospital (CA)
Corresponding author
Drucker, Daniel J
Venue
Endocrine Reviews
Published
2020-04-15
Volume
41
Issue
3
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W3015989800
Cited by
399
References
132
Citations by year
2026: 5 · 2025: 9 · 2024: 13 · 2023: 37 · 2022: 72 · 2021: 100 · 2020: 162
FWCI
14.19
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novo Nordisk Fonden (NNF19SA0035502)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
type 2 diabetes, COVID-19 pandemic, SARS-CoV-2, ACE2, dipeptidyl peptidase IV, DPP-4 inhibitors, glucose-lowering agents, immunomodulation, glucose homeostasis, inflammation
MeSH terms
Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Insulin, Peptidyl-Dipeptidase A, Lung, Obesity, Pneumonia, Viral, Receptors, Virus, Risk Factors, Serine Endopeptidases, Coronavirus Infections, Dipeptidyl Peptidase 4, Gastrointestinal Tract, Dipeptidyl-Peptidase IV Inhibitors, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.